Your search for ‘McGuireWoods LLP’ returned 3,630 results

BDO Consulting has published an interesting infographic we think healthcare investors may be interested in.

A new column from Becker's Hospital Review identifies 50 things to know about healthcare costs.

It's no secret that while some U.S. hospitals are thriving, others are struggling under the weight of decreasing reimbursement, rising expenses and pressures relative to integrated care.

On November 2, President Obama signed into the law the Bipartisan Budget Act of 2015 (the "Act"), which contains language that will significantly change how hospital-based outpatient care is reimbursed.

The Ninth Circuit recently upheld California’s Proposition 2, Cal. Health & Safety Code §§ 25990-25991, agreeing with the U.S. District Court for the Central District of California that the new shelled egg law is constitutional

Castle Biosciences, headquartered in Friendswood, Texas, is a cancer-focused molecular diagnostics company which currently offers prognostic tests for patients.

CMS has announced it will extend the federal programs to encourage hospitals and physicians to adopt electronic health records — with Stage 2 now starting in 2015 and continuing through 2016, and Stage 3 beginning in 2017 for providers that have completed two or more years at that lower level.

In a notice published on Feb. 2, 2012, in the Federal Register, the Centers for Medicare & Medicaid Services (CMS) solicited public comment on the applicability of the Emergency Medical Treatment and Active Labor Act (EMTALA) to inpatients and hospitals with specialized capabilities.

Ranking GOP members of the House of Representatives Committee on Energy and Commerce sent a letter to the Food and Drug Administration.

Congressional lawmakers have reached a bipartisan agreement that would repeal and replace the sustainable growth rate Medicare physician payment formula.

In a November 2009 speech before the Tenth Annual Pharmaceutical Regulatory and Compliance Congress in Washington D.C., Assistant Attorney General Lanny A. Breuer put big pharma on notice that DOJ intended to aggressively investigate potential violations of the FCPA within the pharmaceutical and medical device industry.

On May 1 the U.S. Food and Drug Administration changed the way expert panels analyze whether a medical device should be approved for the general market, hoping a new approach will streamline the premarket process and improve discussions.

On Dec. 31, 2012, FDA released new Guidance for Industry on its Refuse to Accept Policy for 510(k) notifications.

Fiscal 2013 user fee payments by industry may be inaccessible to FDA if planned budget cuts take effect.

In recent months, FDA has been ramping up inspections of manufacturers who have pending filings for approval, notifications and other regulatory clearances.

On Dec. 22, 2010, the Government Accountability Office (GAO) released a report highlighting key differences in federal oversight standards among long-term acute care hospitals (LTACHs) and certain other classes of hospitals and skilled nursing facilities.

3 Boomerang Capital has announced a majority growth investment in Enjoin.

Adaptive Biotechnologies has announced it has completed a series C financing round and completed a newly created series D round of financing.